Volver a Agenda
Session Chair(s)
Karen Jaffe
Consultant, United States
Learning Objective : Discuss the issues surrounding introducing legislation; Describe the relationship between legislation and the implementation of regulatory modification; Discuss the impact of legislation on the various stakeholders in the drug development process.
Speaker(s)
Panelist
Juergen Froehlich
Aradigm Corporation, United States
Chief Medical Officer
Panelist
Marc M. Boutin, JD
Novartis , Switzerland
Global Head of Patient Engagement and Advocacy
Panelist
Steven Walker
Abigail Alliance, United States
Co-founder
Panelist
Carla Mann Woods
Fight to Live, United States
CEO and Founder
¿Tiene una cuenta?